Showing results (1591-1600 of 1,768) with videos related to

Sort By:
Pageof 177
The Journal of Chemical Physics|April 1, 2025
Exploring superconductivity under strong coupling with the vacuum electromagnetic fieldA Thomas, E Devaux, K Nagarajan, et al.
JAMA Network Open|April 18, 2024
Incidence of Total Knee Arthroplasty After Arthroscopic Surgery for Knee Osteoarthritis: A Secondary Analysis of a Randomized Clinical TrialTrevor B Birmingham, Codie A Primeau, Salimah Z Shariff, et al.
Neurology|November 14, 2025
Natural History of Children and Adolescents With Dravet Syndrome: A 24-Month Follow-UpJoseph Sullivan, Elaine C Wirrell, Kelly G Knupp, et al.
Scientific Reports|January 21, 2018
The action of a negative allosteric modulator at the dopamine D<sub>2</sub> receptor is dependent upon sodium ionsChristopher J Draper-Joyce, Ravi Kumar Verma, Mayako Michino, et al.
Angewandte Chemie (International Ed. in English)|February 10, 2024
Discovery of the First-in-Class Inhibitors of Hypoxia Up-Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast ActivationDimitra Papadopoulou, Vasiliki Mavrikaki, Filippos Charalampous, et al.
Biochimie|April 22, 2017
Leishmania donovani tyrosyl-tRNA synthetase structure in complex with a tyrosyl adenylate analog and comparisons with human and protozoan counterpartsXimena Barros-Álvarez, Keshia M Kerchner, Cho Yeow Koh, et al.
Diabetologia|February 1, 1997
Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 familiesG Velho, H Blanché, M Vaxillaire, et al.
Molecular Pharmacology|August 6, 2021
Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D<sub>2</sub> Dopamine ReceptorR Benjamin Free, Caroline A Cuoco, Bing Xie, et al.
Advanced Healthcare Materials|March 14, 2014
Lipid-like nanomaterials for simultaneous gene expression and silencing in vivoYizhou Dong, Ahmed A Eltoukhy, Christopher A Alabi, et al.
Molecular Therapy Oncolytics|October 11, 2021
Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activationAnna Mistarz, Matthew Graczyk, Marta Winkler, et al.
Pageof 177